Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2024-11-04 00:00:00 ET · period of report 2024-11-01 · accession 0001127602-24-026383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-04 | 2024-11-01 | MAIA | CHAOUKI STEVEN M | Dir | P - Purchase | $2.51 | +22.1K | 111.0K | +25% | +$55.6K |
| D | 2024-11-04 | 2024-11-01 | MAIA | CHAOUKI STEVEN M | Dir | P - Purchase | $2.26 | +22.1K | 22.1K | New | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | P | A | 22,133 | $2.51 | 111,024 | D | — | — | (F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. |
| 2 | Derivative | Warrants | 2024-11-01 | P | A | 22,133 | $2.26 | 22,133 | D | $2.26 · 2025-05-01 to 2030-05-01 | 22,133 Common Stock | (F2) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date. |